logo
Plus   Neg
Share
Email

NewRiver REIT To Acquire Remaining 50% Stake In BRAVO JVs For GBP 59.4 Mln Cash

NewRiver REIT plc (NRR.L) announced Thursday that it has now exchanged conditional contracts to acquire the remaining 50% share in its BRAVO Joint Ventures from subsidiaries of BRAVO II for a cash consideration of 59.4 million pounds

With the deal, NewRiver will gain control over 4 convenience-led shopping centre assets in Belfast, Glasgow, Hastings and Middlesbrough with a total gross asset value of 240 million pounds, representing a topped up net initial yield of 7.3%.

The transaction is expected to increase Funds From Operations in the year to March 2018 by 4.2 million pounds, with a 5.4 million pounds increase in net rental income and a 1.2 million increase pounds in net finance costs. The transaction is expected to generate additional annualised accounting net rental income of 8.3 million pounds.

The BRAVO Joint Ventures generated net rental income of approximately 16.5 million pounds for the financial year 2016 and had net assets of approximately 120.8 million pounds, of which the Group's share was approximately 60.4 million pounds.

The JVs have indebtedness of approximately 120 million pounds outstanding which the Company intends to remain in place and bring onto its own balance sheet following completion of the acquisition.

The acquisition is conditional on obtaining funding which the Company intends to be satisfied by means of 59.4 million pounds of the net proceeds of the capital raising announced on June 15.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT